Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Gross Profit (2020 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Gross Profit for 10 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 18.63% year-over-year to $1.6 million, compared with a TTM value of $4.8 million through Dec 2025, up 74.52%, and an annual FY2025 reading of $5.1 million, up 376.2% over the prior year.
  • Gross Profit was $1.6 million for Q4 2025 at Neuroone Medical Technologies, up from $1.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $1.9 million in Q4 2024 and bottomed at -$36223.0 in Q1 2022.
  • Average Gross Profit over 5 years is $405726.6, with a median of $167358.5 recorded in 2023.
  • The sharpest move saw Gross Profit tumbled 71.49% in 2022, then soared 3899.56% in 2023.
  • Year by year, Gross Profit stood at -$13096.0 in 2021, then grew by 6.02% to -$12307.0 in 2022, then skyrocketed by 2263.92% to $266314.0 in 2023, then soared by 623.54% to $1.9 million in 2024, then decreased by 18.63% to $1.6 million in 2025.
  • Business Quant data shows Gross Profit for NMTC at $1.6 million in Q4 2025, $1.5 million in Q3 2025, and $914835.0 in Q2 2025.